Home » UCB Sells Anti-Haemorrhagic Drug to Eumedica
UCB Sells Anti-Haemorrhagic Drug to Eumedica
UCB announced that it has agreed to sell world-wide rights to its anti-haemorrhagic product Somatostatine-UCB to Eumedica.
The Earth Times
The Earth Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May